Aerie pharmaceuticals to host key opinion leader event on dry eye disease: current landscape, unmet needs, and emerging treatment options

Durham, n.c.--(business wire)--aerie pharmaceuticals, inc. (nasdaq: aeri), a pharmaceutical company focused on the discovery, development, and commercialization of first-in-class ophthalmic therapies, today announced that it will host a key opinion leader (kol) webinar on friday, september 23, 2022 from 10:00 a.m. – 11:30 a.m. eastern time. the event will feature dr. laura periman, md, of the periman eye institute, and dr. john sheppard, md, of the virginia eye consultants, who will discuss new
AERI Ratings Summary
AERI Quant Ranking